Latest News by Industry
DUBLIN--(BUSINESS WIRE)--Sep 19, 2022--
The "Influenza Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.
The global influenza diagnostics market size reached US$ 828.8 Million in 2021. Looking forward, the publisher expects the market to reach US$ 1,237.54 Million by 2027, exhibiting a CAGR of 6.91% during 2021-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Influenza Diagnostics Market Trends:
The elevating prevalence of several chronic diseases, such as asthma, chronic obstructive pulmonary disease (COPD), bronchiectasis, cystic fibrosis, etc., that increase the risk of influenza, is primarily driving the global influenza diagnostics market. Besides this, the expanding geriatric population, who are more prone to respiratory tract infections, is also catalyzing the market growth. Additionally, the rising availability of advanced diagnostic immunoassay formats along with the growing usage of miniaturized devices in influenza diagnostics is positively influencing the global market.
Moreover, the introduction of CLIA-waived POC molecular influenza tests and the shifting consumer preferences from centralized laboratories to decentralized point-of-care testing are also augmenting the market growth. In addition to this, the emerging popularity of rapid influenza diagnostic test (RIDT) that are convenient to use and provide results in approximately fifteen minutes is acting as a significant growth-inducing factor.
Furthermore, various initiatives by WHO to strengthen influenza surveillance, monitoring, and data utilization, are also stimulating the market growth. In line with this, numerous government bodies are becoming more actively involved in taking preventative steps to reduce the risk of influenza. For instance, the U.S. CDC and the South-East Asian Region (SEAR) have collaborated to support non-researched bilateral influenza as a response to avian, seasonal, and pandemic influenza. In the coming years, the growing integration of artificial intelligence (AI) in influenza diagnostics to minimize the timelines for sample processing and facilitate error-free results is expected to drive the global influenza diagnostics market.
Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global influenza diagnostics market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, test type, type of flu and end user.
Breakup by Product:
Breakup by Test Type:
Breakup by Type of Flu:
Breakup by End User:
Breakup by Region:
Key Topics Covered:
1 Preface
2 Scope and Methodology
3 Executive Summary
4 Introduction
5 Global Influenza Diagnostics Market
6 Market Breakup by Product
7 Market Breakup by Test Type
8 Market Breakup by Type of Flu
9 Market Breakup by End User
10 Market Breakup by Region
11 SWOT Analysis
12 Value Chain Analysis
13 Porters Five Forces Analysis
14 Price Analysis
15 Competitive Landscape
Companies Mentioned
For more information about this report visit https://www.researchandmarkets.com/r/pttoy2
View source version on businesswire.com:https://www.businesswire.com/news/home/20220919005577/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: INFECTIOUS DISEASES PHARMACEUTICAL HEALTH MEDICAL DEVICES
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 09/19/2022 09:53 AM/DISC: 09/19/2022 09:53 AM
http://www.businesswire.com/news/home/20220919005577/en